{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:04:43Z","timestamp":1790690683075,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"DOI":"10.1007\/s00125-026-06882-4","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:16:53Z","timestamp":1790687813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety of glucagon-like peptide-1 receptor agonists and other new-generation glucose-lowering agents for the management of type 2 diabetes in pregnancy: a French nationwide population-based study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2398-0396","authenticated-orcid":false,"given":"Mathis","family":"Collier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9626-3571","authenticated-orcid":false,"given":"Laurent","family":"Chouchana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7842-5602","authenticated-orcid":false,"given":"Florentia","family":"Kaguelidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2045-4742","authenticated-orcid":false,"given":"Jean-Marc","family":"Treluyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7535-5517","authenticated-orcid":false,"given":"Anick","family":"B\u00e9rard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"6882_CR1","unstructured":"Sapra A, Bhandari P (2025) Diabetes. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available from http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551501\/. Accessed 27 January 2026"},{"issue":"3","key":"6882_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.7326\/M18-1900","volume":"170","author":"C Ke","year":"2019","unstructured":"Ke C, Lau E, Shah BR et al (2019) Excess burden of mental illness and hospitalization in young-onset type 2 diabetes: a population-based cohort study. Ann Intern Med 170(3):145\u2013154. https:\/\/doi.org\/10.7326\/M18-1900","journal-title":"Ann Intern Med"},{"issue":"7560","key":"6882_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/bmj.38856.692986.AE","volume":"333","author":"MCM Macintosh","year":"2006","unstructured":"Macintosh MCM, Fleming KM, Bailey JA et al (2006) Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ 333(7560):177. https:\/\/doi.org\/10.1136\/bmj.38856.692986.AE","journal-title":"BMJ"},{"issue":"4","key":"6882_CR4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ajog.2024.11.026","volume":"232","author":"NS Clement","year":"2025","unstructured":"Clement NS, Abul A, Farrelly R et al (2025) Pregnancy outcomes in type 2 diabetes: a systematic review and meta-analysis. Am J Obstet Gynecol 232(4):354\u2013366. https:\/\/doi.org\/10.1016\/j.ajog.2024.11.026","journal-title":"Am J Obstet Gynecol"},{"key":"6882_CR5","unstructured":"European Platform on Rare Disease Registration. Available from https:\/\/eu-rd-platform.jrc.ec.europa.eu. Accessed 6 February 2026"},{"issue":"1","key":"6882_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/bdrc.21090","volume":"105","author":"A Ornoy","year":"2015","unstructured":"Ornoy A, Reece EA, Pavlinkova G, Kappen C, Miller RK (2015) Effect of maternal diabetes on the embryo, fetus, and children: congenital anomalies, genetic and epigenetic changes and developmental outcomes. Birth Defects Res Part C Embryo Today Rev 105(1):53\u201372. https:\/\/doi.org\/10.1002\/bdrc.21090","journal-title":"Birth Defects Res Part C Embryo Today Rev"},{"key":"6882_CR7","unstructured":"Market Intelligence Report: Antidiabetic Drugs, 2012-2021 (2023) Available from https:\/\/www.canada.ca\/en\/patented-medicine-prices-review\/services\/npduis\/analytical-studies\/mir-antidiabetic-drugs-2012-2021.html. Accessed 27 January 2026"},{"key":"6882_CR8","unstructured":"Cloppet-Fontaine A, Grenet G, Pinto T, Blanchard S, Haute Autorit\u00e9 de Sant\u00e9 (HAS) (2024) Strat\u00e9gie th\u00e9rapeutique du patient vivant avec un diab\u00e8te de type 2 [Clinical practice guidelines] Available from https:\/\/www.has-sante.fr\/jcms\/p_3191108\/fr\/strategie-therapeutique-du-patient-vivant-avec-un-diabete-de-type-2. Accessed 18 May 2026 [article in French]"},{"issue":"1","key":"6882_CR9","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvaf116","volume":"193","author":"JA Wyckoff","year":"2025","unstructured":"Wyckoff JA, Lapolla A, Asias-Dinh BD et al (2025) Preexisting diabetes and pregnancy: an Endocrine Society and European Society of Endocrinology joint clinical practice guideline. Eur J Endocrinol 193(1):G1-48. https:\/\/doi.org\/10.1093\/ejendo\/lvaf116","journal-title":"Eur J Endocrinol"},{"key":"6882_CR10","doi-asserted-by":"publisher","unstructured":"Darmon P, Bauduceau B, Bordier L et al (2023) Prise de position de la Soci\u00e9t\u00e9 Francophone du Diab\u00e8te (SFD) sur les strat\u00e9gies d\u2019utilisation des traitements anti-hyperglyc\u00e9miants dans le diab\u00e8te de type 2 - 2023. M\u00e9decine Mal M\u00e9taboliques. La maladie r\u00e9nale chronique dans le diab\u00e8te de type 217(8):664\u201393. https:\/\/doi.org\/10.1016\/j.mmm.2023.10.007 [article in French]","DOI":"10.1016\/j.mmm.2023.10.007"},{"issue":"1","key":"6882_CR11","first-page":"14","volume":"65","author":"NM Ivers","year":"2019","unstructured":"Ivers NM, Jiang M, Alloo J et al (2019) Diabetes Canada 2018 clinical practice guidelines. Can Fam Physician 65(1):14\u201324","journal-title":"Can Fam Physician"},{"key":"6882_CR12","unstructured":"The Society of Obstetricians and Gynaecologists of Canada (n.d.) Your pregnancy. Available from https:\/\/www.pregnancyinfo.ca\/your-pregnancy\/special-consideration\/unintended-pregnancy\/. Accessed 27 January 2026"},{"issue":"3","key":"6882_CR13","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3390\/ijms25031909","volume":"25","author":"P Pavli","year":"2024","unstructured":"Pavli P, Triantafyllidou O, Kapantais E, Vlahos NF, Valsamakis G (2024) Infertility improvement after medical weight loss in women and men: a review of the literature. Int J Mol Sci 25(3):1909. https:\/\/doi.org\/10.3390\/ijms25031909","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6882_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ajog.2024.08.024","volume":"232","author":"RF Drummond","year":"2025","unstructured":"Drummond RF, Seif KE, Reece EA (2025) Glucagon-like peptide-1 receptor agonist use in pregnancy: a review. Am J Obstet Gynecol 232(1):17\u201325. https:\/\/doi.org\/10.1016\/j.ajog.2024.08.024","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"6882_CR15","doi-asserted-by":"publisher","first-page":"e083550","DOI":"10.1136\/bmjopen-2023-083550","volume":"14","author":"K Dao","year":"2024","unstructured":"Dao K, Shechtman S, Weber-Schoendorfer C et al (2024) Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services. BMJ Open 14(4):e083550. https:\/\/doi.org\/10.1136\/bmjopen-2023-083550","journal-title":"BMJ Open"},{"issue":"2","key":"6882_CR16","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1001\/jamainternmed.2023.6663","volume":"184","author":"CE Cesta","year":"2024","unstructured":"Cesta CE, Rotem R, Bateman BT et al (2024) Safety of GLP-1 receptor agonists and other second-line antidiabetics in early pregnancy. JAMA Intern Med 184(2):144\u2013152. https:\/\/doi.org\/10.1001\/jamainternmed.2023.6663","journal-title":"JAMA Intern Med"},{"issue":"2","key":"6882_CR17","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/ijgo.15092","volume":"163","author":"K Skov","year":"2023","unstructured":"Skov K, Mandic IN, Nyborg KM (2023) Semaglutide and pregnancy. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet 163(2):699\u2013700. https:\/\/doi.org\/10.1002\/ijgo.15092","journal-title":"Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet"},{"issue":"Suppl 4","key":"6882_CR18","doi-asserted-by":"publisher","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","volume":"65","author":"P Tuppin","year":"2017","unstructured":"Tuppin P, Rudant J, Constantinou P et al (2017) Value of a national administrative database to guide public decisions: from the syst\u00e8me national d\u2019information interr\u00e9gimes de l\u2019Assurance Maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France. Rev Epidemiol Sante Publique. 65(Suppl 4):S149-167. https:\/\/doi.org\/10.1016\/j.respe.2017.05.004","journal-title":"Rev Epidemiol Sante Publique."},{"key":"6882_CR19","doi-asserted-by":"publisher","unstructured":"Bezin J, Duong M, Lassalle R et al (2017) The national healthcare system claims databases in France, SNIIRAM and EGB:\u00a0powerful\u00a0tools for pharmacoepidemiology. Pharmacoepidemiol Drug Saf 26(8):954\u2013962. https:\/\/doi.org\/10.1002\/pds.4233","DOI":"10.1002\/pds.4233"},{"issue":"6","key":"6882_CR20","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.therap.2023.01.010","volume":"78","author":"S de Germay","year":"2023","unstructured":"de Germay S, Conte C, Micallef J et al (2023) Performing pharmacoepidemiological studies using the French health insurance data warehouse (SNDS): how to translate guidelines into practice. Therapie 78(6):691\u2013703. https:\/\/doi.org\/10.1016\/j.therap.2023.01.010","journal-title":"Therapie"},{"issue":"6","key":"6882_CR21","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.therap.2024.05.003","volume":"79","author":"O Maillard","year":"2024","unstructured":"Maillard O, Bun R, Laanani M et al (2024) Use of the French National Health Data System (SNDS) in pharmacoepidemiology: a systematic review in its maturation phase. Therapie 79(6):659\u2013669. https:\/\/doi.org\/10.1016\/j.therap.2024.05.003","journal-title":"Therapie"},{"issue":"7","key":"6882_CR22","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/pds.4556","volume":"27","author":"PO Bloti\u00e8re","year":"2018","unstructured":"Bloti\u00e8re PO, Weill A, Dalichampt M et al (2018) Development of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases: an application to antiepileptic drug use in 4.9 million pregnant women in France. Pharmacoepidemiol Drug Saf 27(7):763\u2013770. https:\/\/doi.org\/10.1002\/pds.4556","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"6882_CR23","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jcf.2025.03.002","volume":"24","author":"L Chouchana","year":"2025","unstructured":"Chouchana L, Collier M, Martin C, Burgel PR, Treluyer JM (2025) CFTR modulators and pregnancy outcomes: early findings from a nationwide cohort study. J Cyst Fibros Off J Eur Cyst Fibros Soc 24(3):469\u2013475. https:\/\/doi.org\/10.1016\/j.jcf.2025.03.002","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"issue":"2","key":"6882_CR24","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.fertnstert.2025.04.005","volume":"124","author":"M Bourdon","year":"2025","unstructured":"Bourdon M, Santulli P, Beeker N et al (2025) Impact of clomiphene citrate on multiple gestation births and perinatal outcomes: a nationwide cohort study. Fertil Steril 124(2):334\u2013343. https:\/\/doi.org\/10.1016\/j.fertnstert.2025.04.005","journal-title":"Fertil Steril"},{"issue":"1","key":"6882_CR25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/cid\/ciae610","volume":"81","author":"M Collier","year":"2025","unstructured":"Collier M, Chouchana L, Frange P et al (2025) Risk of neurodevelopmental disorders in children exposed to HIV and antiretrovirals in utero: a national cohort study in France. Clin Infect Dis Off Publ Infect Dis Soc Am 81(1):92\u2013100. https:\/\/doi.org\/10.1093\/cid\/ciae610","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"10","key":"6882_CR26","doi-asserted-by":"publisher","first-page":"e2538039","DOI":"10.1001\/jamanetworkopen.2025.38039","volume":"8","author":"C Bernard","year":"2025","unstructured":"Bernard C, Duchemin T, Marty L et al (2025) First-trimester mRNA COVID-19 vaccination and risk of major congenital anomalies. JAMA Netw Open 8(10):e2538039. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.38039","journal-title":"JAMA Netw Open"},{"issue":"4","key":"6882_CR27","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s00125-017-4206-6","volume":"60","author":"C Billionnet","year":"2017","unstructured":"Billionnet C, Mitanchez D, Weill A et al (2017) Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012. Diabetologia 60(4):636\u2013644. https:\/\/doi.org\/10.1007\/s00125-017-4206-6","journal-title":"Diabetologia"},{"issue":"1","key":"6882_CR28","doi-asserted-by":"publisher","first-page":"e0295897","DOI":"10.1371\/journal.pone.0295897","volume":"19","author":"M Louchet","year":"2024","unstructured":"Louchet M, Collier M, Beeker N et al (2024) Trends in harmful drug exposure during pregnancy in France between 2013 and 2019: a nationwide cohort study. PloS One 19(1):e0295897. https:\/\/doi.org\/10.1371\/journal.pone.0295897","journal-title":"PloS One"},{"issue":"12","key":"6882_CR29","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s40262-018-0668-z","volume":"57","author":"S Hall","year":"2018","unstructured":"Hall S, Isaacs D, Clements JN (2018) Pharmacokinetics and clinical implications of semaglutide: a new glucagon-like peptide (GLP)-1 receptor agonist. Clin Pharmacokinet 57(12):1529\u20131538. https:\/\/doi.org\/10.1007\/s40262-018-0668-z","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"6882_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ejmg.2018.03.008","volume":"61","author":"A Kinsner-Ovaskainen","year":"2018","unstructured":"Kinsner-Ovaskainen A, Lanzoni M, Garne E et al (2018) A sustainable solution for the activities of the European network for surveillance of congenital anomalies: EUROCAT as part of the EU Platform on Rare Diseases Registration. Eur J Med Genet 61(9):513\u2013517. https:\/\/doi.org\/10.1016\/j.ejmg.2018.03.008","journal-title":"Eur J Med Genet"},{"issue":"11","key":"6882_CR31","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/jech-2011-200311","volume":"66","author":"C Pornet","year":"2012","unstructured":"Pornet C, Delpierre C, Dejardin O et al (2012) Construction of an adaptable European transnational ecological deprivation index: the French version. J Epidemiol Community Health 66(11):982\u2013989. https:\/\/doi.org\/10.1136\/jech-2011-200311","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"6882_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12874-024-02447-4","volume":"25","author":"E Micolon","year":"2025","unstructured":"Micolon E, Loubiere S, Zimmermann A, Berbis J, Auquier P, Courbiere B (2025) Development and validation of a model to identify polycystic ovary syndrome in the French national administrative health database. BMC Med Res Methodol 25(1):5. https:\/\/doi.org\/10.1186\/s12874-024-02447-4","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"6882_CR33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s40264-024-01496-4","volume":"48","author":"M Tisseyre","year":"2025","unstructured":"Tisseyre M, Collier M, Beeker N, Kaguelidou F, Treluyer JM, Chouchana L (2025) Prenatal exposure to proton pump inhibitors and risk of serious infections in offspring during the first year of life: a nationwide cohort study. Drug Saf 48(3):265\u2013277. https:\/\/doi.org\/10.1007\/s40264-024-01496-4","journal-title":"Drug Saf"},{"issue":"9","key":"6882_CR34","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/MLR.0000000000001745","volume":"60","author":"A Rachas","year":"2022","unstructured":"Rachas A, Gastaldi-M\u00e9nager C, Denis P et al (2022) The economic burden of disease in France from the national health insurance perspective: the healthcare expenditures and conditions mapping used to prepare the French Social Security Funding Act and the Public Health Act. Med Care 60(9):655\u2013664. https:\/\/doi.org\/10.1097\/MLR.0000000000001745","journal-title":"Med Care"},{"issue":"2","key":"6882_CR35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2337\/diacare.28.2.323","volume":"28","author":"TD Clausen","year":"2005","unstructured":"Clausen TD, Mathiesen E, Ekbom P, Hellmuth E, Mandrup-Poulsen T, Damm P (2005) Poor pregnancy outcome in women with type 2 diabetes. Diabetes Care 28(2):323\u2013328. https:\/\/doi.org\/10.2337\/diacare.28.2.323","journal-title":"Diabetes Care"},{"issue":"24","key":"6882_CR36","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1001\/jama.2025.20951","volume":"334","author":"J Maya","year":"2025","unstructured":"Maya J, Pant D, Fu Y et al (2025) Gestational weight gain and pregnancy outcomes after GLP-1 receptor agonist discontinuation. JAMA 334(24):2186\u20132196. https:\/\/doi.org\/10.1001\/jama.2025.20951","journal-title":"JAMA"},{"issue":"23","key":"6882_CR37","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1042\/CS20258493","volume":"139","author":"L Dearden","year":"2025","unstructured":"Dearden L, Ozanne SE (2025) Incretin receptor agonism during pregnancy: implications for mother and baby. Clin Sci 139(23):1597\u20131610. https:\/\/doi.org\/10.1042\/CS20258493","journal-title":"Clin Sci"},{"issue":"3","key":"6882_CR38","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.3390\/ijms25031882","volume":"25","author":"P Chandrasekaran","year":"2024","unstructured":"Chandrasekaran P, Weiskirchen R (2024) The role of obesity in type 2 diabetes mellitus-an overview. Int J Mol Sci 25(3):1882. https:\/\/doi.org\/10.3390\/ijms25031882","journal-title":"Int J Mol Sci"},{"key":"6882_CR39","doi-asserted-by":"publisher","first-page":"110859","DOI":"10.1016\/j.diabres.2023.110859","volume":"203","author":"SF Sajjadi","year":"2023","unstructured":"Sajjadi SF, Sacre JW, Chen L, Wild SH, Shaw JE, Magliano DJ (2023) Algorithms to define diabetes type using data from administrative databases: a systematic review of the evidence. Diabetes Res Clin Pract 203:110859. https:\/\/doi.org\/10.1016\/j.diabres.2023.110859","journal-title":"Diabetes Res Clin Pract"},{"issue":"1059","key":"6882_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/postgradmedj-2013-132068","volume":"90","author":"S Seidu","year":"2014","unstructured":"Seidu S, Davies MJ, Mostafa S, de Lusignan S, Khunti K (2014) Prevalence and characteristics in coding, classification and diagnosis of diabetes in primary care. Postgrad Med J 90(1059):13\u201317. https:\/\/doi.org\/10.1136\/postgradmedj-2013-132068","journal-title":"Postgrad Med J"},{"key":"6882_CR41","doi-asserted-by":"publisher","first-page":"100137","DOI":"10.1016\/j.deman.2023.100137","volume":"10","author":"S Fuentes","year":"2023","unstructured":"Fuentes S, Hrzic R, Haneef R, Kab S, Cosson E, Fosse-Edorh S (2023) Identifying type 1\/type 2 diabetes in medico-administrative database to improve health surveillance, medical research and prevention in diabetes: algorithm development and application. Diabetes Epidemiol Manag 10:100137. https:\/\/doi.org\/10.1016\/j.deman.2023.100137","journal-title":"Diabetes Epidemiol Manag"},{"issue":"2","key":"6882_CR42","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3390\/ijms27020759","volume":"27","author":"C Voros","year":"2026","unstructured":"Voros C, Chatzinikolaou F, Papapanagiotou I et al (2026) A systematic review on GLP-1 receptor agonists in reproductive health: integrating IVF data, ovarian physiology and molecular mechanisms. Int J Mol Sci 27(2):759. https:\/\/doi.org\/10.3390\/ijms27020759","journal-title":"Int J Mol Sci"},{"issue":"5","key":"6882_CR43","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/AOG.0000000000002579","volume":"131","author":"DM Haas","year":"2018","unstructured":"Haas DM, Marsh DJ, Dang DT et al (2018) Prescription and other medication use in pregnancy. Obstet Gynecol 131(5):789\u2013798. https:\/\/doi.org\/10.1097\/AOG.0000000000002579","journal-title":"Obstet Gynecol"},{"issue":"2","key":"6882_CR44","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s40259-024-00699-6","volume":"39","author":"N Haddy","year":"2025","unstructured":"Haddy N, Jourdain H, Desplas D et al (2025) Use of semaglutide (Wegovy) in adults in France: a nationwide drug utilization study. BioDrugs Clin Immunother Biopharm Gene Ther 39(2):321\u2013332. https:\/\/doi.org\/10.1007\/s40259-024-00699-6","journal-title":"BioDrugs Clin Immunother Biopharm Gene Ther"},{"issue":"1","key":"6882_CR45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.diabet.2014.11.007","volume":"41","author":"E Eschwege","year":"2015","unstructured":"Eschwege E, Basdevant A, Crine A, Moisan C, Charles MA (2015) Type 2 diabetes mellitus in France in 2012: results from the ObEpi survey. Diabetes Metab 41(1):55\u201361. https:\/\/doi.org\/10.1016\/j.diabet.2014.11.007","journal-title":"Diabetes Metab"},{"issue":"3","key":"6882_CR46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.pedneo.2014.10.002","volume":"56","author":"AC Egbe","year":"2015","unstructured":"Egbe AC (2015) Birth defects in the newborn population: race and ethnicity. Pediatr Neonatol 56(3):183\u2013188. https:\/\/doi.org\/10.1016\/j.pedneo.2014.10.002","journal-title":"Pediatr Neonatol"},{"key":"6882_CR47","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (2025) WEGOVY (s\u00e9maglutide) - Ob\u00e9sit\u00e9. Available from https:\/\/www.has-sante.fr\/jcms\/p_3562976\/fr\/wegovy-semaglutide-obesite. Accessed 27 January 2026 [article in French]"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06882-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-026-06882-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06882-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:16:57Z","timestamp":1790687817000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-026-06882-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":47,"alternative-id":["6882"],"URL":"https:\/\/doi.org\/10.1007\/s00125-026-06882-4","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"4 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Data cannot be made publicly available due to French data privacy laws and SNDS policy.","order":1,"name":"Ethics","label":"Data availability","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.","order":2,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":3,"name":"Ethics","label":"Authors\u2019 relationships and activities","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"MC, LC, FK, JMT and AB designed the study. MC extracted and analysed the data. MC, LC and AB interpreted the data. MC and AB drafted the manuscript. LC, FK, JMT and AB critically revised the manuscript for important intellectual content. MC is the guarantor of the study. All authors read and approved the final version of the manuscript. The corresponding author attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted.","order":4,"name":"Ethics","label":"Contribution statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}